COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff May 15, 2017)

Similar documents
COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff July 1, 2017)

COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff Aug 1, 2017)

COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff Aug 1, 2017)

COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff Jan 1, 2018)

COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff July 1, 2018) Provider Type 32: Opioid Treatment Program

Service Description Rate Unit Service Limits Combination of Service Rules

Medicaid Treatment and Service Fees for Substance Use Disorder (SUD): CY

2017 Drug Screen Tests

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Medical Policy Outpatient Drug Screening and Testing. No Prior Authorization X X

MEDICAL POLICY Drug Testing

Drug Testing Policy. Approved By 05/10/2017. Application This reimbursement policy applies to UnitedHealthcare Community Plan Medicaid products.

MEDICAL POLICY Drug Testing

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED:

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None

Opioid Treatment Program Reimbursement Re-bundling Proposal

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

MEDICAL POLICY No R2 DRUG TESTING

Drug Testing Policy. Approved By 06/14/2017

2017 Drug Screening Code Updates for WV Medicaid. Prior Authorization for Drug Screening Codes Beyond Service Limits

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

2018 Drug Screening Code Updates for WV Medicaid

Prevention of Fetal Alcohol Spectrum Disorder Coding Basics

Clinical Drug Screening and/or Drug Testing

B. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or

Clinical Drug Screening and/or Drug Testing

Addiction and Recovery Treatment Services (ARTS) Reimbursement Structure

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Calendar Year (CY) 2017 Clinical Laboratory Fee Schedule (CLFS) Final Determinations

distinguish between structural isomers (but not necessarily stereoisomers), including, but not

Controlled Substance Monitoring and Drugs of Abuse Testing Determination

In-OfficeLabTesting. Effective date: August 1, 2017

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

In Office Lab Testing

Cigna Medical Coverage Policy

BUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Based on our criteria and assessment of the peer-reviewed literature, presumptive (immunoassay) in office or pointof-care

MAGELLAN VA MEDICAID/DMAS RATES

MAGELLAN VA MEDICAID/DMAS RATES

Clinical Policy: Buprenorphine-Naloxone (Bunavail, Suboxone, Zubsolv) Reference Number: CP.PMN.81 Effective Date: Last Review Date: 02.

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Clinical UM Guideline

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: CP.MP.HN 542

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Claims Edit Guideline: Drug Testing

DMHAS ASAM SERVICE DESCRIPTIONS

Clinical Policy: Buprenorphine-Naloxone (Suboxone, Bunavail, Zubsolv) Reference Number: CP.PMN.XX. Line of Business: Medicaid

PROCEDURE CODES & UNIT

URINE DRUG TESTING FOR SUBSTANCE ABUSE TREATMENT AND CHRONIC PAIN MANAGEMENT

Urine Drug Testing for Substance Use and Pain Management

Contractor Information. LCD Information

Comment Number. Date Comment Received

Corporate Medical Policy

9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone)

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

Management Options for Opioid Dependence:

See Important Reminder at the end of this policy for important regulatory and legal information.

Prepublication Requirements

The CARA & Buprenorphine Prescribing for APNs & PAs

Coding for Preventive Services A Guide for HIV Providers

Closing the Loop in Treating Opioid Addiction:

Clinical Policy: Outpatient Testing for Drugs of Abuse

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

Policy Evaluation: Substance Use Disorders

Community Behavioral Health Services. Fee Schedule

Fighting Today s Opioid Epidemic

VIRGINIA MEDICAID ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS) OFFICE BASED OPIOID PROVIDER (OBOT) PAYMENT MODEL 3 rd Annual Mental Health Summit

Medication Assisted Treatment: Buprenorphine Clinical Coverage Policy 8A-3 Amended Date: 10/1/2015 DRAFT Table of Contents

NURSING INTAKE. Provider Name: Provider Signature: Nursing Summary. Are you pregnant at this time?

Frequently Asked Questions about Florida s Opioid STR Grant

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.

Vivitrol Drug Court and Medication Assisted Treatment

COURT OF COMMON PLEAS DRUG DIVERSION PROGRAM

VIRGINIA MEDICAID PERSPECTIVE ON BEST PRACTICES IN THE TREATMENT OF OPIOID USE DISORDER

Addiction Recovery Treatment Services (ARTS): Billing Best Practices. December 2017

Medication-Assisted Treatment (MAT) Overview

Medicaid and the Opioid Crisis

Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Clinical Policy: Naltrexone (Vivitrol) Reference Number: CP.PHAR.96 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Policy: Naltrexone (Vivitrol) Reference Number: CP.PHAR.96 Effective Date: Last Review Date: Line of Business: Medicaid

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

LOUISIANA MEDICAID PROGRAM ISSUED: 02/01/12 REPLACED: 02/01/94 CHAPTER 5: PROFESSIONAL SERVICES SECTION 5.1: COVERED SERVICES PAGE(S) 6

RI Centers of Excellence for the

Intensive Behavioral Therapy for Obesity Guidelines

Urine Drug/Alcohol Testing HMO

Urine Drug/Alcohol Testing

HUSKY Health Benefits and Prior Authorization Requirements Grid* Behavioral Health Partnership Effective: January 1, 2012

Opioid State Targeted Response (STR) Project

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Family Health Centers of San Diego Alcohol and Other Drug Services

Outpatient Therapy Services

Requirements for Nurse Practitioners to Prescribe Buprenorphine-Naloxone (Suboxone):

Massachusetts Medicaid pediatric high-risk asthma bundled payment pilot

Transcription:

COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff May 15, 2017) Provider Type 32: Opioid Treatment Program Procedure Code Service Description Rate Unit Service Limits H0001 Alcohol and/or Drug Assessment $144.84 Per assessment H0004 Individual Outpatient Therapy $20.40 H0005 Group Oupatient Therapy $39.78 Per 15 minute increment Per 60-90 minute session Can only be billed once per 12-months per participant per provider unless there is more than a 30 day break in treatment. Providers may not bill for more than six units per day per participant. Provider may not bill for more than one Level I Group counseling session per day per participant. Combination of Service Rules N/A H0015 or H2036 H0015 or H2036 H0016 Methadone Services H0020: Modifier MAT Initial induction: Alcohol/Drug Services; Medical/Somatic (Medical Intervention in Ambulatory Setting) $204.00 Initial Induction period Methadone Maintenance $63.00 Per Week Provider may bill once per seven days only in the first week of treatment or after a break in treatment H0014 of 6 months. Provider may bill once per seven days when the patient has been seen at least once during the month; Providers may bill with Induction during the first week only. Cannot bill this with H0014 or H0047 W9520 Methadone guest dosing $9.00 Per day receiving medication at guest program Guest dosing may be billed once per day that the patient is receiving their medication at the guest dosing program. One patient is eligible for up to 30 N/A days of guest dosing per year. Additional days may be used with clinical reasoning. Zubsolv Services (Buprenorphine/Naloxone) Ongoing services (Buprenorphine/Naloxone): H0047 Alcohol/Other Drug Abuse Services, Not Otherwise Specified $56.00 Per Week Provider may bill once per seven days when the patient has been seen at least once during the month; Providers may bill with Induction during the first week only. Cannot bill this with H0014, or H0020 1

W9521 Buprenorphine guest dosing $8.00 Per day receiving medication at guest program Guest dosing may be billed once per day that the patient is receiving their medication at the guest dosing program. One patient is eligible for up to 30 N/A days of guest dosing per year. Additional days may be used with clinical reasoning. Medication management provided by Physicians, Nurse Practitioners, and Physician Assistants may be reimbursed using E&M codes. 99211: Modifier Management, including Rx -Minimal) $20.26 Per visit 99212: Modifier Management, including Rx -Straight $43.96 Per visit 99213: Modifier $73.47 Per visit For most providers and most participants, twelve Cannot bill with H0014 Management, including Rx -Low times a year will be sufficient. or H0016 99214: Modifier Management, including Rx -Moderately $108.04 Per visit 99215: Modifier Management, including Rx -Highly complex) $145.44 Per visit All lab tests are included in the bundled rate for OTPs. OTPs negotiate their rates with labs directly. 2

Provider Type 50: OHCQ Certified of Licensed Substance Use Disorder Treatment Program Procedure Code Service Description Rate Unit Service Limits Combination of Service Rules Can only be billed once per 12-months per H0001 Alcohol and/or Drug Assessment $144.84 Per assessment participant per provider unless there is more than a N/A 30 day break in treatment. H0004 Individual Outpatient Therapy $20.40 H0005 Group Outpatient Therapy $39.78 H0015 Intensive Outpatient (IOP) $127.50 Per 15 minute increment Per 60-90 minute session Per diem with a minimum of 2 hours of service per day Providers may not bill for more than six units per day per participant. Provider may not bill for more than one Level I Group counseling session per day per participant. Providers may bill for maximum of 4 days per week. Services for participants who require a minimum of 9 hrs of service per week for an adult and 6 hrs per week for adolescents. Cannot bill this with H0015 or H2036. Cannot be billed by the PT 50 while patient in OTP. Cannot bill this with H0015 or H2036. Cannot be billed by the PT 50 while patient in OTP. Cannot bill with H0004, H0005, or H2036 H2036 Partial Hospitalization $132.60 Per diem Providers may bill once per day and sessions shall be a minimum of 2 hours per day. Services for participants who require 20 weekly hours of structured outpatient treatment. H0004, H0005, or H0015 H2036: Modifier 22 Partial hospitalization (6+ hrs/day of services) $214.20 Per diem Providers may bill one per day and sessions shall be a minimum of 6 hours per day. Services for participants who require 20 weekly hours of structured outpatient treatment. H0004, H0005, or H0016 H0014 ADAA Certified Ambulatory Detox Program $71.40 Per diem Max of 5 days. Cannot be billed while patient in OTP. 3

80305 Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (eg, immunoassay) capable of being read by direct optical observation only (eg, dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service $11.81 Per screen This is the only lab category reimbursable to PT 50. If additional labs are required, they may be sent to the Lab for testing. All lab testing is subject to Departmental review and audit. Provider Type 50s that employ DATA 2000 WAIVED PRACITIONERS may be reimbursed for Medication Assisted Treatment for SUD using E&M 99211: Modifier Management, including Rx -Minimal) $20.26 Per visit 99212: Modifier 99213: Modifier 99214: Modifier 99215: Modifier Management, including Rx -Straight forward) Management, including Rx -Low complexity) Management, including Rx -Moderately complex) Management, including Rx -Highly complex) $43.96 Per visit $73.47 Per visit $108.04 Per visit $145.44 Per visit For most providers and most participants, twelve times a year will be sufficient. Cannot bill with H0014. Cannot be billed by PT 50 while patient in OTP. 4

Medication Assisted Treatment BUPRENORPHINE The codes below apply to PT 32, or PT 50 that is administering buprenorphine directly to patients. When the provider has ordered and paid for the drug directly through the manufacturer, the provider will reimburse based on the dosage of the administered medication to the patient. The J codes may NOT be used when prescribing the medication, or when the medication is obtained from the pharmacy where the point of sale occurred. Procedure Code Service Description Rate Unit Service Limits J0572: Modifier 51 J0572 (No modifier) J0573 ZUBSOLV 1.4-0.36 MG TABLET MUST INCLUDE NDC: 54123-0914- 30 ZUBSOLV 2.9-0.71 MG TABLET MUST INCLUDE NDC: 54123-0929- 30 ZUBSOLV 5.7-1.4 MG TABLET S MUST INCLUDE NDC: 54123-0957- 30 $3.69 $7.39 $7.39 Vivitrol: Must include NDC 65757- Maximum of 380 units per dose. Minimum age of J2315 $2.43 Per unit 0300-01 use is 18. Buprenorphine only tablets may be used for pregnant women (Subutex), and in other limited circumstances when it is contra-indicated to use of buprenorphine/naloxone. Use of Subutex will be reviewed for clinical necessity. In these limited circumstances the following NDCs must be included on the claim. J0571: Modifier Use of Subutex will be reviewed for clinical Subutex 2 mg NDC below $1.13 2 mg 51 necessity. J0571 (no Use of Subutex will be reviewed for clinical Subutex 8 mg NDC below $1.83 8 mg modifier) necessity. In addition to the Zubsolv codes listed above, the following codes may be used for Suboxone film when clinically indicated (document in patient chart, subject to review) J0574 J8499 Buprenorphine: Film Must include NDC: 12496-1208-03 Buprenorphine: Film Must include NDC: 12496-1202-03 $7.80 8mg $4.36 2mg Clinical dose may require multiple strengths per day and may be reimbursed in combinations that reach that clinical dose. Clinical dose may require multiple strengths per day and may be reimbursed in combinations that reach that clinical dose. Clinical dose may require multiple strengths per day and may be reimbursed in combinations that reach that clinical dose. Use of Suboxone film shall be clinically indicated and documented in the patient chart. Use of Suboxone film shall be clinically indicated and documented in the patient chart. 5

Buprenorphine NDC codes NDC Drug Name Price 00054-0176-13 BUPRENORPHINE 2 MG TABLET S $1.13 00054-0177-13 BUPRENORPHINE 8 MG TABLET S $1.83 00093-5378-56 BUPRENORPHINE 2 MG TABLET S $1.13 00093-5379-56 BUPRENORPHINE 8 MG TABLET S $1.83 00228-3153-03 BUPRENORPHINE 8 MG TABLET S $1.83 00228-3156-03 BUPRENORPHINE 2 MG TABLET S $1.13 00378-0923-93 BUPRENORPHINE 2 MG TABLET S $1.13 00378-0924-93 BUPRENORPHINE 8 MG TABLET S $1.83 50383-0924-93 BUPRENORPHINE 2 MG TABLET S $1.13 50383-0930-93 BUPRENORPHINE 8 MG TABLET S $1.83 VIVITROL The codes below apply to community based providers that are administering vivitrol directly to patients. When the provider has ordered and paid for the drug in advance, directly through the manufacturer, medicaid will reimburse based on the dosage of the administered drug to the Medicaid patient. The J codes may NOT be used when prescribing the medication, or when the medication is obtained from the pharmacy where the point of sale occurred. Procedure Code Service Description Rate Unit J2315 Vivitrol: Must include NDC 65757-- 0300-01 $2.43 Per unit 96372- Therapeutic Injection $19.87 Per injection Service Limits Maximum of 380 units per dose. Minimum age of use is 18. Limit one injection per month. 6

Any DATA 2000 Waived Practitioner (MD, NP, PA) and Local Health Department with DATA 2000 Waived Practitioners Procedure Code Service Description Rate Unit 99201 $43.41 Per visit Including Rx-Minimal, new patient) 99202 $73.84 Per visit Including Rx-Straight forward, new patient) 99203 $106.80 Per visit Including Rx-Low complexity, new patient) 99204 $162.35 Per visit Including Rx-Moderately complex, new patient) 99205 $203.38 Per visit Including Rx-Highly complex, new patient) 99211 Management, including Rx -Minimal) $20.26 Per visit 99212 Management, including Rx -Straight forward) $43.96 Per visit 99213 Management, including Rx -Low complexity) $73.47 Per visit 99214 Management, including Rx -Moderately complex) $108.04 Per visit 99215 Management, including Rx -Highly complex) $145.44 Per visit 7

Provider Type 10: Laboratories Effective January 1, 2017 Labs may not bill Medicaid for tests that are sent by OTPs (Provider Type 32) as those labs are billed through negotiated contracts with the OTPs Procedure Code Service Description Rate Unit Service Limits Presumptive Drug Testing. Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (eg, 80305 immunoassay) capable of being read by direct $11.81 optical observation only (eg, dipsticks, cups, cards, Per test cartridges), includes sample validation when performed, per date of service Only 80305 may be billed by CLIA waived providers, the other codes must be sent to Labs. Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (eg, 80306 immunoassay) read by instrument-assisted direct optical observation (eg, dipsticks, cups, cards, $15.86 Per test cartridges), includes sample validation when performed, per date of service Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers (eg, 80307 immunoassay, enzyme assay, TOF, MALDI, $63.45 Per test LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when performed, per date of service This is an expensive test series and must only be used when medically necessary. Definitive Drug Testing. Must be performed by Labs Only: Selection must reflect Medical necessity Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (eg, IA, ELISA, EMIT, FPIA) and enzymatic methods (eg, alcohol dehydrogenase)); qualitative and quantitative, all sources, includes specimen validity testing, per day, per # of drug classes as listed below. Procedure Code Service Description Rate Unit Service Limits Per day, 1-7 drug class(es), including matabolite(s) G0480 $63.55 Per test if performed. Per day, 8-14 drug class(es), including G0481 $97.78 Per test metabolite(s) if performed. 8

The following tests should be used by exception; only when medically necessary to have a complete panel of drugs as determined by presumptive tests G0482 Per day, 15-21 drug class(es), including metabolite(s) if performed. $131.99 Per test G0483 Per day, 22 or more drug class(es), including metabolite(s) if performed. $171.10 Per test This is an expensive test series and must only be used by exception. This is an expensive test series and must only be used by exception. 9